Crossref

1. Nucleoside/nucleotide analog inhibitors of hepatitis B virus polymerase: mechanism of action and resistance

- Luis Menéndez-Arias

- Mar Álvarez

- Beatriz Pacheco

2. Substitutions of rtL228 and/or L229 are involved in the regulation of replication and HBsAg secretion in hepatitis B virus, and do not affect susceptibility to nucleos(t)ide analogs

- Bo Qin

- Yechao Zhou

- Guozhong Zhou

- Xiuping Xu

- Yanan Wang

- Jinkun Chen

3. Variability in the Responses of Hepatitis B Virus D-Subgenotypes to Antiviral Therapy: Designing Pan-D-Subgenotypic Reverse Transcriptase Inhibitors

- Mousumi Khatun

- Krishna Kumar

- Ayana Baidya

- Rajiv Kumar Mondal

- Ondřej Baszczyňski

- Filip Kalčic

- Soma Banerjee

- Gopal Krishna Dhali

- Kausik Das

- Abhijit Chowdhury

- Zlatko Janeba

- Saikat Chakrabarti

- Simanti Datta

- J.-H. James Ou

4. Whole genome analysis of hepatitis B virus before and during long-term therapy in chronic infected patients: Molecular characterization, impact on treatment and liver disease progression

- Zeineb Belaiba

- Kaouther Ayouni

- Mariem Gdoura

- Wafa Kammoun Rebai

- Henda Touzi

- Amel Sadraoui

- Walid Hammemi

- Lamia Yacoubi

- Salwa Abdelati

- Lamine Hamzaoui

- Mohamed Msaddak Azzouz

- Anissa Chouikha

- Henda Triki

5. HBV Drug Resistance Substitutions Existed before the Clinical Approval of Nucleos(t)ide Analogues: A Bioinformatic Analysis by GenBank Data Mining

- Xizhan Xu

- Kuanhui Xiang

- Mingze Su

- Yao Li

- Wei Ji

- Yutang Li

- Hui Zhuang

- Tong Li